CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED

Other languages China Shineway Pharmaceutical Group Limited

Equities

2877

KYG2110P1000

Market Closed - Hong Kong S.E. Other stock markets 01:38:34 17/07/2024 pm IST			5-day change	1st Jan Change
7.95 ^HKD	-0.25%		-3.17%	+9.35%

29/03	China Shineway Pharmaceutical Group Grows 2023 Profit, Declares Interim 2024 Dividend	MT
28/03	China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China Shineway Pharmaceutical Group Grows 2023 Profit, Declares Interim 2024 Dividend	29/03
China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
China Shineway Pharmaceutical Group Limited Declares First Interim Dividend in Respect of the Year Ending December 31, 2024, Payable on May 17, 2024	28/03
China Shineway Pharmaceutical to Log Higher Profit in 2023; Shares Up 3%	08/03
China Shineway Pharmaceutical Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023	07/03
China Shineway Pharmaceutical Logs 22% Rise in Q1-Q3 Turnover	03/11
China Shineway Pharmaceutical Group Limited Announces Resignation of Executive Director	31/23/31
China Shineway Pharmaceutical Group Limited Announces Resignation of Liu Tiejun as Executive Director, Effective 1 November 2023	31/23/31
China Shineway Pharmaceutical’s Profit Rises 48% in H1	30/23/30
China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30
China Shineway Pharmaceutical Group Limited Proposes Second Interim Dividend in Respect of the Fiscal Year 2023, Payable on 29 September 2023	30/23/30
China BlueChemical, Unit to Invest in Structured Deposit Products	03/23/03
China Shineway Pharmaceutical’s H1 Profit to Rise By Up to 50%	03/23/03
China Shineway Pharmaceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023	03/23/03
Bank of China Raises 30 Billion Yuan with Bond Issue	16/23/16
Shineway Pharmaceutical's Q1 Turnover Rises 36%	08/23/08
China Shineway Pharmaceutical Group's 2022 Profit Jumps 29.8%	30/23/30
China Shineway Pharmaceutical Group Limited Announces First Interim Dividend in Respect of the Fiscal Year 2023, Payable on 17 May 2023	30/23/30
China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30
China Shineway Pharmaceutical Group Limited Announces Board Changes	20/23/20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages China Shineway Pharmaceutical Group Limited

Equities

2877

KYG2110P1000

Other languages

Filters